Cesar Adrian Martinez Longoria

Dr. Cesar Adrian Martinez Longoria

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
CLCesar Adrian Martinez Longoria
Cesar Adrian Martinez Longoria
GRGloria María Rosales-Solis
Gloria María Rosales-Solis
JOJorge Ocampo-Garza
Jorge Ocampo-Garza
GGGuillermo Antonio Guerrero-González
Guillermo Antonio Guerrero-González
JOJorge Ocampo-Candiani
Jorge Ocampo-Candiani
Ecthyma gangrenosum is a rare skin infection classically associated with Pseudomonas aeruginosa. We performed a retrospective study of all cases diagnosed with ecthyma gangrenosum from 2004-2010 in a university hospital in Mexico (8 cases, 5 female patients and 3 male patients, ages between 4 months and 2 years). The most common risk factor for ecthyma gangrenosum is neutropenia in immunocompromised patients. In previously healthy patients, immunological evaluation is important to rule out underlying immunodeficiency. Ecthyma gangrenosum in healthy patients has a high mortality rate and early diagnosis and aggressive antibiotic treatment is imperative as it can improve patients' prognosis.

18 July 2013 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
GGGloria M. González
Gloria M. González
Rogelio de J. Treviño-RangelRogelio de J. Treviño-Rangel
Rogelio de J. Treviño-Rangel
JPJosé P. Palma-Nicolás
José P. Palma-Nicolás
CLCesar Adrian Martinez Longoria
Cesar Adrian Martinez Longoria
JGJ. Gerardo González
J. Gerardo González
ABAlexandro Bonifaz
Alexandro Bonifaz
To establish the species distribution and in vitro susceptibilities of 358 bloodstream fungal isolates from paediatric patients in Mexico. Isolates were collected during a 2 year surveillance programme in 14 medical centres in 10 Mexican states. A molecular approach was used to determine the Candida parapsilosis species complex. In vitro susceptibility to amphotericin B, fluconazole, voriconazole, itraconazole, posaconazole, caspofungin, anidulafungin and micafungin was determined according to CLSI procedures. Species-specific clinical breakpoints for fluconazole, voriconazole and echinocandins were applied. Candida spp. accounted for 98.33% of fungaemias, including 127 Candida albicans isolates, 127 C. parapsilosis complex isolates (121 C. parapsilosis sensu stricto, 4 Candida orthopsilosis and 2 Candida metapsilosis strains) and 72 Candida tropicalis isolates. C. albicans and C. parapsilosis complex were the species predominant in neonates (48 cases each; 41.02%). C. parapsilosis complex was also the predominant species in patients 1 month to <2 years of age (P = 0.007). In contrast, C. albicans was the most frequent species in patients aged 2 to <12 years (P = 0.003). Antifungal resistance was rare among the subset of isolates. Candida glabrata showed the highest resistance rate to amphotericin B (1/9 isolates), fluconazole (1/9 isolates) and itraconazole (2/9 isolates). The species distribution differed with the age of the patients, with C. albicans and C. parapsilosis complex being the most commonly isolated species. C. glabrata showed the highest resistance rate to amphotericin B, fluconazole and itraconazole. This is the first study of fungaemia episodes in Mexican children.

31 August 2004 in Pediatric Neurology
Verified
Journal Article
Closed access
PDF file
CLCesar Adrian Martinez Longoria
Cesar Adrian Martinez Longoria
JMJosé J. Morales-Aguirre
José J. Morales-Aguirre
CVClaudia P. Villalobos-Acosta
Claudia P. Villalobos-Acosta
DGDemóstenes Gómez-Barreto
Demóstenes Gómez-Barreto
MCMiguel Cashat-Cruz
Miguel Cashat-Cruz

3 June 2009 in Vector-Borne and Zoonotic Diseases
Verified
Journal Article
Closed access
Maria Lourdes Garza-RodríguezMaria Lourdes Garza-Rodríguez
Maria Lourdes Garza-Rodríguez
DRDiana R. Rodríguez Rodriguez
Diana R. Rodríguez Rodriguez
BBBradley J. Blitvich
Bradley J. Blitvich
Miguel Angel Reyes-LopezMiguel Angel Reyes-Lopez
Miguel Angel Reyes-Lopez
IFIldefonso Fernández-Salas
Ildefonso Fernández-Salas
ARAna M. Rivas-Estilla
Ana M. Rivas-Estilla
A clinical and serological investigation was performed to determine the presence of West Nile virus (WNV) among febrile and encephalitic patients in northern Mexico. In addition, asymptomatic blood donors were serologically assayed for WNV to determine the seroprevalence of WNV in the general population. The study cohort consisted of 1432 individuals (588 febrile patients, 44 encephalitic patients, and 800 asymptomatic blood donors). All subjects were negative for WNV IgM. Sixty subjects were reactive for dengue virus (DENV) IgM (16 blood donors and 44 febrile patients). A subset ( n = 425) of individuals was also screened by ELISA for flavivirus IgG. The prevalence of flavivirus IgG in febrile patients, encephalitic patients, and blood donors ranged from 40% to 59%. A subset ( n = 147) of sera reactive for flavivirus IgG was further tested by plaque reduction neutralization test. Six individuals with no history of travel during the preceding 12 months were seropositive for WNV. Another 65 individuals were seropositive for DENV1 and 24 were seropositive for DENV2. The high prevalence of dengue antibodies in northern Mexico appears to limit the incidence of WNV infection in this region. Article Summary Line: Antibodies to WNV, DENV-1, and DENV-2 were identified in humans in northern Mexico.

1 April 2015 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
CLCesar Adrian Martinez Longoria
Cesar Adrian Martinez Longoria
NRNadina Eugenia Rubio-Perez
Nadina Eugenia Rubio-Perez
JRJosue Emmanuel Rios-Solis
Josue Emmanuel Rios-Solis
FGFernando Garcia-Rodriguez
Fernando Garcia-Rodriguez
The incidences of infection with Mycobacterium tuberculosis and Cryptococcus neoformans in immunocompromised patients have increased, but there are few documented cases of their coexistence. We present the case of a 9-year-old female with systemic lupus erythematosus (SLE), treated with prednisone and cyclophosphamide, who was admitted to the emergency department with a 2-week history of fever, headache, malaise, fatigue, and diplopia 3 years after diagnosis. Physical examination showed limitation of abduction of the right eye, Kernig and Brudzinski signs, and hyporeflexia. Magnetic resonance imaging showed hyperdense lesions located in the caudate nucleus, and lumbar puncture showed pleocytosis, a low glucose level, and increased protein level. Cerebrospinal fluid culture identified C. neoformans and PCR detect M. tuberculosis. Treatment was started with isoniazid, rifampin, pyrazinamide, ethambutol, and amphotericin B. We found two similar reports in adults, but no data were found for either pediatric or SLE patients.

1 January 2016 in Therapeutic Advances in Vaccines
Verified
Journal Article
Open access
Enrique Chacon-CruzEnrique Chacon-Cruz
Enrique Chacon-Cruz
CLCesar Adrian Martinez Longoria
Cesar Adrian Martinez Longoria
ELEduardo Llausas-Magana
Eduardo Llausas-Magana
ALAntonio Luevanos-Velazquez
Antonio Luevanos-Velazquez
JVJorge Alejandro Vazquez-Narvaez
Jorge Alejandro Vazquez-Narvaez
RRRicardo Ruttimann
Ricardo Ruttimann
Meningococcal meningitis is reported as a rare condition in Mexico. There are no internationally published studies on bacterial causes of meningitis in the country based on active surveillance. This study focuses on finding the etiology of bacterial meningitis in children from nine Mexican Hospitals. From January 2010 to February 2013, we conducted a three years of active surveillance for meningitis in nine hospitals throughout Mexico. Active surveillance started at the emergency department for every suspected case, and microbiological studies confirmed/ruled out all potentially bacterial pathogens. We diagnosed based on routine cultures from blood and cerebrospinal fluid (not polymerase chain reaction or other molecular diagnostic tests), and both pneumococcal serotyping and meningococcal serogrouping by using standard methods. Neisseria meningitidis was the leading cause, although 75% of cases occurred in the northwest of the country in Tijuana on the US border. Serogroup C was predominant. Streptococcus pneumoniae followed Neisseria meningitides, but was uniformly distributed throughout the country. Serotype 19A was the most incident but before universal implementation of the 13-valent pneumococcal conjugate vaccine. Other bacteria were much less common, including Enterobacteriaceae and Streptococcus agalactiae (these two affecting mostly young infants). Meningococcal meningitis is endemic in Tijuana, Mexico, and vaccination should be seriously considered in that region. Continuous universal vaccination with the 13-valent pneumococcal conjugate vaccine should be nationally performed, and polymerase chain reaction should be included for bacterial detection in all cultures – negative but presumably bacterial meningitis cases.